|
0
Votes
vote
SALVAT submits complete response to FDA approvable letter for CETRAXALSALVAT announced today the submission of the response to the FDA Approvable Letter for CETRAXAL (Ciprofloxacin 0.2% Otic Solution in Single Dose Containers). ... |

